Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.
Saved in:
| Title: | Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. |
|---|---|
| Authors: | Aguirre LE; Department of Internal Medicine, Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT, USA. luis.aguirre@yale.edu.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. luis.aguirre@yale.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. luis.aguirre@yale.edu., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Stahl M; Department of Internal Medicine, Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT, USA. maximilian.stahl@yale.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Nov 04; Vol. 15 (1), pp. 192. Date of Electronic Publication: 2025 Nov 04. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41188211 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aguirre+LE%22">Aguirre LE</searchLink>; Department of Internal Medicine, Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT, USA. luis.aguirre@yale.edu.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. luis.aguirre@yale.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. luis.aguirre@yale.edu.<br /><searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22DeAngelo+DJ%22">DeAngelo DJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stahl+M%22">Stahl M</searchLink>; Department of Internal Medicine, Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT, USA. maximilian.stahl@yale.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Nov 04; Vol. 15 (1), pp. 192. <i>Date of Electronic Publication: </i>2025 Nov 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41188211 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41408-025-01406-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 192 Titles: – TitleFull: Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aguirre LE – PersonEntity: Name: NameFull: Stone RM – PersonEntity: Name: NameFull: DeAngelo DJ – PersonEntity: Name: NameFull: Stahl M IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 11 Text: 2025 Nov 04 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2044-5385 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Blood cancer journal Type: main |
| ResultId | 1 |